Tristel says that fourth quarter sales have improved and its profit for the year to June 2011 will be more than £500,000.
The infection and contamination control products supplier had warned in April that delays to licences and approvals were going to hit the full year figures and profit would be no less than £433,000. FinnCap had originally forecast a profit of £1.9m for the year to June 2011 but this was then slashed to £500,000. At the time that figure appeared relatively optimistic but it has proved to be slightly lower than the outcome.
The licence to sell the Stella tray system in China and the inclusion of Tristelís wipes on Germanyís VAH listing were achieved in the fourth quarter and that is why trading improved. Sales of the Crystel products for the pharmaceutical and personal care market have also commenced. Regulatory approvals have also been gained in Australia and Hong Kong.
At 45.5p a share, up 3.5p, Tristel is valued at £18.2m.
The full year figures will be published on 24 October. Tristel will have net cash at the end of June 2011.
A profit of £1m is forecast for the year to June 2012.
Download the June 2011 edition of AIM Journal at http://www.hubinvest.com/AIMPDFJuly2011_22.pdf
© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.